The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Self-citationShull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V, & Kehrl, J. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4167 · Cited by 2,866
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
Self-citationTGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,385
Self-citationDPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1
Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., et al. (1996) · Science · doi:10.1126/science.271.5247.350 · Cited by 2,337
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,270
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
Self-citation
Cited by
Items 101–154 of 154
Mechanisms of the Epithelial–Mesenchymal Transition by TGF-β
Wendt, M. K., Allington, T. M., & Schiemann, W. P. (2009) · Future Oncology · doi:10.2217/fon.09.90 · Cited by 317
Cytoplasmic PML function in TGF-β signalling
Lin, H.-K., Bergmann, S., & Pandolfi, P. P. (2004) · Nature · doi:10.1038/nature02783 · Cited by 312
TGFβ signalling in control of T-cell-mediated self-reactivity
Rubtsov, Y. P., & Rudensky, A. Y. (2007) · Nature Reviews Immunology · doi:10.1038/nri2095 · Cited by 311
Friese, M. A., Wischhusen, J., Wick, W., Weiler, M., Eisele, G., Steinle, A., & Weller, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1627 · Cited by 305
Emilin1 Links TGF-β Maturation to Blood Pressure Homeostasis
Zacchigna, L., Vecchione, C., Notte, A., Cordenonsi, M., Dupont, S., Maretto, S., Cifelli, G., Ferrari, A., Maffei, A., Fabbro, C., et al. (2006) · Cell · doi:10.1016/j.cell.2005.12.035 · Cited by 298
Thompson, T. B., Lerch, T. F., Cook, R. W., Woodruff, T. K., & Jardetzky, T. S. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.09.008 · Cited by 290
Freudlsperger, C., Bian, Y., Contag Wise, S., Burnett, J., Coupar, J., Yang, X., Chen, Z., & Van Waes, C. (2013) · Oncogene · doi:10.1038/onc.2012.171 · Cited by 290
Halder, S. K., Beauchamp, R. D., & Datta, P. K. (2005) · Neoplasia · doi:10.1593/neo.04640 · Cited by 288
The MicroRNA-17-92 Family of MicroRNA Clusters in Development and Disease
Concepcion, C. P., Bonetti, C., & Ventura, A. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e318258b60a · Cited by 285
Syndecans – key regulators of cell signaling and biological functions
Afratis, N. A., Nikitovic, D., Multhaupt, H. A. B., Theocharis, A. D., Couchman, J. R., & Karamanos, N. K. (2017) · The FEBS Journal · doi:10.1111/febs.13940 · Cited by 283
Henley, S. A., & Dick, F. A. (2012) · Cell Division · doi:10.1186/1747-1028-7-10 · Cited by 281
Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects
López-Hernández, F. J., & López-Novoa, J. M. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1275-6 · Cited by 276
C/EBPβ at the core of the TGFβ cytostatic response and its evasion in metastatic breast cancer cells
Gomis, R. R., Alarcón, C., Nadal, C., Van Poznak, C., & Massagué, J. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.07.019 · Cited by 273
Self-citationThe Role of TGFβ Signaling in Wound Epithelialization
Ramirez, H., Patel, S. B., & Pastar, I. (2014) · Advances in Wound Care · doi:10.1089/wound.2013.0466 · Cited by 273
Epithelial-Mesenchymal Transition in tumor microenvironment
Jing, Y., Han, Z., Zhang, S., Liu, Y., & Wei, L. (2011) · Cell & Bioscience · doi:10.1186/2045-3701-1-29 · Cited by 270
Cheng, N., Bhowmick, N. A., Chytil, A., Gorksa, A. E., Brown, K. A., Muraoka, R., Arteaga, C. L., Neilson, E. G., Hayward, S. W., & Moses, H. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208685 · Cited by 267
PIN1, the cell cycle and cancer
Yeh, E. S., & Means, A. R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2107 · Cited by 267
A map of human cancer signaling
Cui, Q., Ma, Y., Jaramillo, M., Bari, H., Awan, A., Yang, S., Zhang, S., Liu, L., Lu, M., O'Connor‐McCourt, M., et al. (2007) · Molecular Systems Biology · doi:10.1038/msb4100200 · Cited by 262
Zecha, J. A. E. M., Raber-Durlacher, J. E., Nair, R. G., Epstein, J. B., Sonis, S. T., Elad, S., Hamblin, M. R., Barasch, A., Migliorati, C. A., Milstein, D. M. J., et al. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3152-z · Cited by 262
Carbon‐Based Nanomaterials for Cancer Therapy via Targeting Tumor Microenvironment
Saleem, J., Wang, L., & Chen, C. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800525 · Cited by 262
Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositis
Hoshino, K., Muro, Y., Sugiura, K., Tomita, Y., Nakashima, R., & Mimori, T. (2010) · Rheumatology · doi:10.1093/rheumatology/keq153 · Cited by 260
Signaling interplay between transforming growth factor-β receptor and PI3K/AKT pathways in cancer
Zhang, L., Zhou, F., & ten Dijke, P. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.10.001 · Cited by 260
Qian, B., Katsaros, D., Lu, L., Preti, M., Durando, A., Arisio, R., Mu, L., & Yu, H. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0219-7 · Cited by 260
Cellular senescence and cancer treatment
Schmitt, C. A. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.005 · Cited by 254
Scandura, J. M., Boccuni, P., Massagué, J., & Nimer, S. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406771101 · Cited by 254
Self-citationThe emerging role of TGF-β superfamily coreceptors in cancer
Bernabeu, C., Lopez-Novoa, J. M., & Quintanilla, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.07.003 · Cited by 254
TGF-β signaling in cancer metastasis
Xie, F., Ling, L., Van Dam, H., Zhou, F., & Zhang, L. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx123 · Cited by 231
The c‐myc Promoter: Still MysterY and Challenge
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(07)99004-1 · Cited by 211
Targeting TGF-β signaling in cancer
Katz, L. H., Li, Y., Chen, J.-S., Muñoz, N. M., Majumdar, A., Chen, J., & Mishra, L. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.782287 · Cited by 212
Antitumor Activity of EBV-specific T Lymphocytes Transduced With a Dominant Negative TGF-β Receptor
Foster, A. E., Dotti, G., Lu, A., Khalil, M., Brenner, M. K., Heslop, H. E., Rooney, C. M., & Bollard, C. M. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318177092b · Cited by 210
Oncogenic Kras drives invasion and maintains metastases in colorectal cancer
Boutin, A. T., Liao, W.-T., Wang, M., Hwang, S. S., Karpinets, T. V., Cheung, H., Chu, G. C., Jiang, S., Hu, J., Chang, K., et al. (2017) · Genes & Development · doi:10.1101/gad.293449.116 · Cited by 195
Proline biosynthesis is a vent for TGFβ‐induced mitochondrial redox stress
Schwörer, S., Berisa, M., Violante, S., Qin, W., Zhu, J., Hendrickson, R. C., Cross, J. R., & Thompson, C. B. (2020) · The EMBO Journal · doi:10.15252/embj.2019103334 · Cited by 193
Germline Allele-Specific Expression of TGFBR1 Confers an Increased Risk of Colorectal Cancer
Valle, L., Serena-Acedo, T., Liyanarachchi, S., Hampel, H., Comeras, I., Li, Z., Zeng, Q., Zhang, H.-T., Pennison, M. J., Sadim, M., et al. (2008) · Science · doi:10.1126/science.1159397 · Cited by 141
Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review
Christodoulou, I., Goulielmaki, M., Devetzi, M., Panagiotidis, M., Koliakos, G., & Zoumpourlis, V. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1078-8 · Cited by 122
Prunier, C., & Howe, P. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500974200 · Cited by 120
TGF‐β–responsive CAR‐T cells promote anti‐tumor immune function
Hou, A. J., Chang, Z. L., Lorenzini, M. H., Zah, E., & Chen, Y. Y. (2018) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10097 · Cited by 106
The Function of Myostatin in the Regulation of Fat Mass in Mammals
Deng, B., Zhang, F., Wen, J., Ye, S., Wang, L., Yang, Y., Gong, P., & Jiang, S. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-017-0179-1 · Cited by 98
Hannigan, A., Smith, P., Kalna, G., Lo Nigro, C., Orange, C., O’Brien, D. I., Shah, R., Syed, N., Spender, L. C., Herrera, B., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci36125 · Cited by 92
Lenferink, A. E. G., Cantin, C., Nantel, A., Wang, E., Durocher, Y., Banville, M., Paul-Roc, B., Marcil, A., Wilson, M. R., & O'Connor-McCourt, M. D. (2010) · Oncogene · doi:10.1038/onc.2009.399 · Cited by 81
Co-ordination of cell cycle and differentiation in the developing nervous system
Hindley, C., & Philpott, A. (2012) · Biochemical Journal · doi:10.1042/bj20112040 · Cited by 76
Chandhoke, A. S., Karve, K., Dadakhujaev, S., Netherton, S., Deng, L., & Bonni, S. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.152 · Cited by 74
The role of MiRNA-21 in gliomas: Hope for a novel therapeutic intervention?
Aloizou, A.-M., Pateraki, G., Siokas, V., Mentis, A.-F. A., Liampas, I., Lazopoulos, G., Kovatsi, L., Mitsias, P. D., Bogdanos, D. P., Paterakis, K., et al. (2020) · Toxicology Reports · doi:10.1016/j.toxrep.2020.11.001 · Cited by 69
Byun, H.-O., Jung, H.-J., Seo, Y.-H., Lee, Y.-K., Hwang, S.-C., Seong Hwang, E., & Yoon, G. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.04.012 · Cited by 66
Bio-engineering a prevascularized human tri-layered skin substitute containing a hypodermis
Zimoch, J., Zielinska, D., Michalak-Micka, K., Rütsche, D., Böni, R., Biedermann, T., & Klar, A. S. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.07.033 · Cited by 57
Ikeda, M., Morimoto, M., Tajimi, M., Inoue, K., Benhadji, K. A., Lahn, M. M. F., & Sakai, D. (2019) · Investigational New Drugs · doi:10.1007/s10637-018-0636-3 · Cited by 46
Wang, S. E., Narasanna, A., Whitell, C. W., Wu, F. Y., Friedman, D. B., & Arteaga, C. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608499200 · Cited by 41
Akbari, A., Amanpour, S., Muhammadnejad, S., Ghahremani, M. H., Ghaffari, S. H., Dehpour, A. R., Mobini, G. R., Shidfar, F., Abastabar, M., Khoshzaban, A., et al. (2014) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-22-47 · Cited by 33
“Studies showed that TGF-β acts as a double-edged sword in the biological processes [3-6].”
BackgroundHuard, J., Mueller, S., Gilles, E. D., Klingmüller, U., & Klamt, S. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08572.x · Cited by 29
Genome-wide transcriptome profiling of human trabecular meshwork cells treated with TGF-β2
Callaghan, B., Lester, K., Lane, B., Fan, X., Goljanek-Whysall, K., Simpson, D. A., Sheridan, C., & Willoughby, C. E. (2022) · Scientific Reports · doi:10.1038/s41598-022-13573-8 · Cited by 27
“TGF-β 2 is a multifunctional cytokine which controls a wide array of cellular processes including cell growth, differentiation, apoptosis, migration, ECM production, immunity and development 20,21 .”
Famta, P., Shah, S., Vambhurkar, G., Pandey, G., Bagasariya, D., Kumar, K. C., Prasad, S. B., Shinde, A., Wagh, S., Srinivasarao, D. A., et al. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01669-9 · Cited by 21
Olufsen, M., & Arukwe, A. (2011) · Aquatic Toxicology · doi:10.1016/j.aquatox.2011.09.005 · Cited by 20
Strous, M. T. A., Faes, T. K. E., Gubbels, A. L. H. M., van der Linden, R. L. A., Mesker, W. E., Bosscha, K., Bronkhorst, C. M., Janssen-Heijnen, M. L. G., Vogelaar, F. J., & de Bruïne, A. P. (2022) · Clinical and Translational Oncology · doi:10.1007/s12094-021-02746-y · Cited by 20
Expression of TGFβ-1 and EHD1 correlated with survival of non-small cell Lung cancer
Gao, Y., Wang, Y., Sun, L., Meng, Q., Cai, L., & Dong, X. (2014) · Tumor Biology · doi:10.1007/s13277-014-2164-x · Cited by 15
Transcriptional regulators ensuring specific gene expression and decision-making at high TGFβ doses
Hartmann, L., Kristofori, P., Li, C., Becker, K., Hexemer, L., Bohn, S., Lenhardt, S., Weiss, S., Voss, B., Loewer, A., et al. (2025) · Life Science Alliance · doi:10.26508/lsa.202402859 · Cited by 4
Metadata
- Authors
- Siegel, P. M., & Massagué, J.
- Venue
- Nature Reviews Cancer
- Published
- 2003-11
- Volume
- 3
- Issue
- 11
- Pages
- 807-820
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2037038224
- Cited by
- 1,604
- References
- 176
- FWCI
- 5.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.